NNovo Nordisk Read More Novo Nordisk Enters a Pivotal Week: Pipeline Data Meets a Skeptical Market2026-05-31 Novo Nordisk shares slide 35% in 12 months as market awaits pivotal CagriSema Phase 3 results at ADA.…